Related Experiment Video
Updated: Aug 17, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and
1Différenciation cellulaire et prions, CNRS UPR 1983 Institut André Lwoff, 7 rue Guy Môquet, BP8, 94 801 Villejuif Cedex, France. mlocker@vjf.cnrs.fr
Abstract:
During development, antagonists of 5-HT(2) receptor subtypes cause morphological defects of mesodermal and neural crest derivatives including the craniofacial skeleton. We used an inducible mesoblastic cell line, C1, able to fully convert into osteocytes within 12 days, to assess the involvement of 5-HT(2) receptors during osteogenic differentiation. On day 5 of the osteogenic program, immediately before matrix mineralization, the cells selectively implement 5-HT(2B) receptors (5-HT(2B)R) which remain functional until terminal differentiation. In 5-HT-depleted medium, the receptor exhibits a constitutive activity leading to basal nitric oxide (NO) release and phospholipase A2 (PLA2)-dependent arachidonic acid (AA) production. Blockade of this intrinsic activity affects the efficiency of mineralization by decreasing calcium incorporation within the matrix by 40%. Optimal bone matrix mineralization involves both NO and PLA2 signaling pathways. Moreover, between day 5 and day 10, at the beginning of mineral deposition, the 5-HT(2B)R promotes prostaglandin E2 production through AA-dependent cyclooxygenase (COX) activation. From day 10 onwards, when C1 osteoblasts undergo conversion into osteocyte-like cells, COX activity is quenched. Altogether these observations indicate that the 5-HT(2B)R contributes in an autocrine manner to osteogenic differentiation and highlight a switch in the downstream targets of the receptor at the terminal stage of the program. Finally, in addition to its autocrine function, the 5-HT(2B)R responds to 5-HT by increasing NO production and AA release. These findings raise concern regarding the use of 5-HT(2B)R-related drugs that may interfere with bone metabolism in physiological or pathological situations.
Insights
The serotonin 5-HT(2B) receptor is crucial for bone mineralization, regulating nitric oxide and arachidonic acid pathways during osteogenic differentiation. Its activity impacts bone metabolism, raising concerns for related drug use.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Serotonin 5-HT(2) receptor antagonists are linked to developmental defects in mesodermal and neural crest derivatives, including the craniofacial skeleton.
- Osteogenic differentiation is a complex process involving precise molecular signaling for bone formation.
Purpose of the Study:
- To investigate the role of serotonin 5-HT(2) receptors in osteogenic differentiation using an inducible mesoblastic cell line.
- To elucidate the specific contribution of 5-HT(2B) receptors to bone matrix mineralization and related signaling pathways.
Main Methods:
- Utilized an inducible mesoblastic cell line (C1) capable of differentiating into osteocytes.
- Assessed 5-HT(2B) receptor expression and activity during the osteogenic program, focusing on the period before matrix mineralization.
- Measured nitric oxide (NO) release, phospholipase A2 (PLA2)-dependent arachidonic acid (AA) production, and prostaglandin E2 (PGE2) synthesis.
- Quantified calcium incorporation into the bone matrix.
Main Results:
- 5-HT(2B) receptors are selectively expressed on C1 cells by day 5 of osteogenic differentiation, remaining functional until terminal differentiation.
- Constitutive 5-HT(2B) receptor activity in 5-HT-depleted medium results in basal NO release and PLA2-dependent AA production.
- Blocking constitutive 5-HT(2B) receptor activity reduced matrix mineralization by 40% due to decreased calcium incorporation.
- Between days 5 and 10, 5-HT(2B)R signaling promotes PGE2 production via AA-dependent cyclooxygenase (COX) activation.
- COX activity is suppressed after day 10 as cells transition to osteocyte-like phenotypes.
- The receptor responds to exogenous 5-HT by increasing NO production and AA release.
Conclusions:
- 5-HT(2B) receptor plays an autocrine role in osteogenic differentiation, essential for optimal bone matrix mineralization.
- A switch in downstream signaling targets of 5-HT(2B) receptor occurs during the terminal stages of osteocyte differentiation.
- The findings suggest potential interference of 5-HT(2B) receptor-targeting drugs with bone metabolism.
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway
